Activation of human factor XI (plasma thromboplastin antecedent) by factor XIIa (activated Hageman factor)
about
Molecular cloning of platelet factor XI, an alternative splicing product of the plasma factor XI geneActivation of human factor IX (Christmas factor)Covalent structure of human haptoglobin: a serine protease homologFactor XI activation in a revised model of blood coagulation.Alpha-1-antitrypsin-Pittsburgh. A potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf.Characterization of three abnormal factor IX variants (Bm Lake Elsinore, Long Beach, and Los Angeles) of hemophilia-B. Evidence for defects affecting the latent catalytic site.Mechanism of activation of coagulation factor XI by factor XIIa studied with monoclonal antibodies.Regulation of factor Xa in vitro in human and mouse plasma and in vivo in mouse. Role of the endothelium and plasma proteinase inhibitors.Regulation of factor XIa activity by platelets and alpha 1-protease inhibitor.Active site amino acid sequence of human factor D.Isolation and sequence characterization of a cDNA clone of human antithrombin IIIAntibody-probed conformational transitions in the protease domain of human factor IX upon calcium binding and zymogen activation: putative high-affinity Ca(2+)-binding site in the protease domainCharacterization of a heparin-binding site on the catalytic domain of factor XIa: mechanism of heparin acceleration of factor XIa inhibition by the serpins antithrombin and C1-inhibitorMechanism of the participation of the contact system in the Vroman effect. Review and summary.Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis.Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen.Cleavage and inactivation of Factor IX by granulocyte elastase.SERPIN regulation of factor XIa. The novel observation that protease nexin 1 in the presence of heparin is a more potent inhibitor of factor XIa than C1 inhibitor.Intrinsic versus extrinsic coagulation. Kinetic considerations.Replacement of isoleucine-397 by threonine in the clotting proteinase factor IXa (Los Angeles and Long Beach variants) affects macromolecular catalysis but not L-tosylarginine methyl ester hydrolysis. Lack of correlation between the ox brain prothroThe evolutionary relationship of the enzymes involved in blood coagulation and hemostasis.The heparin-catalysed inhibition of human factor XIa by antithrombin III is dependent on the heparin type.Binding of high-molecular-mass kininogen to the Apple 1 domain of factor XI is mediated in part by Val64 and Ile77.Noncovalent interactions of the Apple 4 domain that mediate coagulation factor XI homodimerization.Structural role of Gly(193) in serine proteases: investigations of a G555E (GLY193 in chymotrypsin) mutant of blood coagulation factor XI.An update on factor XI structure and function.factor XI:platelet glycoprotein (GP) Ib:IX:V complex -> factor XIa:platelet glycoprotein (GP) Ib:IX:V complex (XIIa catalyst)Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa.
P2860
Q24318272-7537D35F-D4D1-4DCB-8348-2BE34125BC2EQ24594116-37303B2E-8097-4C1B-98A3-248F9C2D4A12Q24613941-7BAAF773-EEC9-4840-A895-E4F21D174BA1Q34500136-2445725C-007F-4D07-B7E7-504E2B29F5D0Q34522251-C2F511F2-0809-4D65-9E7B-A6BF020E7CD9Q34522488-5C648034-1704-42DE-A132-B79418C58EE4Q34551323-D8F206D3-A004-4D21-BD91-86A5F0672403Q35208212-89ECE88B-355A-4FF8-AB2F-2124EE7553A9Q35582861-9F72ABD0-A0FB-47D1-9897-0EB3DEE77015Q36403576-2F9E2A79-DE7A-466B-8B6A-AD6D94E71665Q36614695-F7125AFF-2CED-47BB-AF7A-2517AEA9FB74Q36761241-F0D77E52-445F-45A8-8101-A4870B5060E7Q37125600-677CDA9F-3863-4910-9FE8-690E36F6244FQ37188939-58C045A6-9345-429F-970E-9BB6ABA876B0Q37402410-ED273D62-AE85-4166-8FFD-6B3E4BACBF72Q40680878-E5ED5082-78B7-4C33-9E2D-33FCEA4F5846Q40682368-5729AAAD-BA35-4339-BDF7-4E0D63C48645Q40856786-999CC88A-3C6D-44F3-9BE8-538704A5FC65Q41875932-80AE41D2-ACF7-4EDB-9112-DDAF24D2E957Q41999331-5F10EA42-0CBE-46FD-A360-5D3256C5640CQ42077532-C3FAA9C3-658F-4FCD-AE4D-969ABFF231DEQ42820775-1682A8DF-BBCF-4A95-AB39-C7886D1D86B6Q42829851-E70CCF04-3901-429E-8DA2-97E343543CF5Q43510603-0D784CE1-BB27-453A-9136-4783EB24E3C9Q44848234-1024E2B2-D67A-4E55-9CC9-9D80618AE425Q47311661-C1A3D82F-3620-43B0-8890-3BF826F274CFQ50291192-9D783133-8093-4119-BA61-B9970C730D49Q50335789-1B18BCDB-A1C0-4F9F-8792-7CE96F3F52F1
P2860
Activation of human factor XI (plasma thromboplastin antecedent) by factor XIIa (activated Hageman factor)
description
1977 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1977 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1977
@ast
im Dezember 1977 veröffentlicher wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1977/12/27)
@sk
vědecký článek publikovaný v roce 1977
@cs
wetenschappelijk artikel (gepubliceerd op 1977/12/27)
@nl
наукова стаття, опублікована в грудні 1977
@uk
مقالة علمية (نشرت في 27-12-1977)
@ar
name
Activation of human factor XI ...... IIa (activated Hageman factor)
@ast
Activation of human factor XI ...... IIa (activated Hageman factor)
@en
Activation of human factor XI ...... IIa (activated Hageman factor)
@nl
type
label
Activation of human factor XI ...... IIa (activated Hageman factor)
@ast
Activation of human factor XI ...... IIa (activated Hageman factor)
@en
Activation of human factor XI ...... IIa (activated Hageman factor)
@nl
prefLabel
Activation of human factor XI ...... IIa (activated Hageman factor)
@ast
Activation of human factor XI ...... IIa (activated Hageman factor)
@en
Activation of human factor XI ...... IIa (activated Hageman factor)
@nl
P356
P1433
P1476
Activation of human factor XI ...... IIa (activated Hageman factor)
@en
P2093
E. W. Davie
K. Kurachi
P304
P356
10.1021/BI00645A030
P407
P577
1977-12-27T00:00:00Z